Electrovaya Secures Landmark Safety Approval for Heavy-Duty Electric Vehicle Batteries
Mississauga, Tuesday, 10 March 2026.
Electrovaya has become the first company to achieve a rigorous safety certification for high-voltage commercial vehicle batteries, cementing its leadership in the accelerating electric fleet industry.
Rigorous Testing Validates Infinity Battery Technology
On March 9, 2026, Electrovaya Inc. (TSE: ELVA) announced the successful completion of the UL 2580 safety certification for six models of its next-generation high-voltage lithium-ion battery systems [1][2]. This certification, which the company claims is the first of its kind for high-voltage systems in its target class, involved a battery of stringent evaluations, including fire propagation, vibration, mechanical shock, and short-circuit testing [1]. The certified platforms are specifically designed for integrated material-handling vehicles operating in all-season outdoor environments and utilize Electrovaya’s proprietary Infinity Battery Technology paired with an advanced thermal management system [1][2].
Expanding Manufacturing and Market Position
To meet anticipated future demand, Electrovaya is aggressively scaling its North American production capabilities. The company is currently expanding its United States manufacturing footprint at a 21-hectare site in Jamestown, New York [1]. This location includes a 12,773-square-meter facility that is slated to become the company’s first gigafactory [1]. This U.S. expansion complements Electrovaya’s existing operational base, which includes two Canadian facilities dedicated to research, engineering, and product commercialization [1][2].
Broader Battery Sector Dynamics
The complexities and capital demands of the battery and energy storage market were further highlighted today, March 10, 2026, when peer manufacturer Ultralife Corporation (NASDAQ: ULBI) released its fourth-quarter and full-year 2025 financial results [3]. While Ultralife reported a solid revenue increase to $48.5 million in the fourth quarter of 2025—up from $43.9 million in the same period of 2024, representing an increase of 10.478 percent—the company also recorded a substantial $12.2 million intangible-asset impairment charge [3]. This impairment drove Ultralife to a Generally Accepted Accounting Principles (GAAP) net loss of $7.4 million, or $0.45 per share, for the quarter [3].